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role, in line with Hem/HCT department and nursing leader-
ship goals. Improve patient outcomes through evidence
based practice and collaborationwith multidisciplinary team
throughout the decision making process. Maintain autono-
mous professional nursing role while providing empower-
ment and role satisfaction.
Intervention: Shared governance education was provided
to staff followed by an electronic survey to gauge interest in
creating and participating in a unit based council. A subset
of volunteers was selected to serve on the newly created
UBC. Through an evidence based approach, a charter
was established. Members serve as representatives of our
NC/CTN staff within which members rotate leadership
positions.
Evaluation/Discussion: Once the charter was developed and
approved, per quorum, work commenced on the initiatives:
1) Ownership of ‘the patient and family transplant education
class’ was returned to the NC staff. This opportunity for
change resulted from an issue identiﬁed in a “management
of daily improvement” (MDI) huddle. 2) The material taught
was reviewed and updated to current practice, utilizing input
from a non-UBC sub-committee. To date, we have seen an
overall increase in attendance and have established
measurable units. It is too early to determine degree of
success, however this initiative will help better serve our
patients, improve outcomes and allow us to address future
concerns with measurable targets. 3) A staff satisfaction
survey was developed, implemented, analyzed and pre-
sented. Ideas to improve overall satisfaction are currently
underway. 4) Creation of a standard orientation work ﬂow
process, role speciﬁc checklists and central orientation
binder for reference of the deﬁned standards, is work in
progress. Each group in the NC/CTN ofﬁce has their own
orientation model without a universal process between
groups. To address this need, a structured framework was
applied to the existing process in attempt to streamline the
comprehensive orientation process and centralize references
for new employees joining the group.
Future and on-going projects include: 1) Standardize
documentation; 2) Collect professional articles that repre-
sent current ‘best’ evidence based practices for imple-
mentation; 3) Create reward and recognition programwithin
NC/CTN group; and 4) Update annual review evaluation
forms.489
2012 BMT ICU Utilization Project Update
Trisha Jenkins. BMT Nursing, Stanford Hospital, Stanford, CA
Signiﬁcance & Background: Resource utilization in health-
care continues to be a top priority. The rising cost of
healthcare and limited resources, including ICU beds, makes
appropriate utilization of the ICU a critical issue.10 years ago,
our BMT Program developed and began utilizing ICU
admission criteria. We have monitored ICU utilization by
collecting data on whether patients met criteria for ICU
admission, the reason for transfer, the length stay and
outcomes. Historically, BMT patients are high acuity and now
older patients with co-morbidities are candidates for trans-
plant. Appropriate ICU utilization is an important goal of our
program.
Purpose: The 10 years of data allows us to evaluate proba-
bilities of survival following ICU with the goal of appropriate
ICU utilization.Interventions: We have developed and continue to revise
ICU admission criteria based on ongoing review of the ICU
data. An understanding of outcomes following ICU is used by
the medical team to counsel patients and families facilitating
informed decisions about their care. To improve the care of
patients in the ICU, the BMT and ICU teams round together
daily including a discussion of goals of care and family
meetings every 2-3 days.
Evaluation: Ongoing evaluation determines if ICU admission
criteria was met, reasons for transfer, length of stay and
outcomes. Most of the patients transferred to the ICU meet
our established criteria. We have noted trends for patients
transferred to the ICU more than once have very poor
outcomes. Additionally, the length of ICU stay predicts for
poor outcomes.
Discussion: Ongoing evaluation of our ICU utilization data
and reviews of the literature provide the BMT team with
information that can be used to counsel patients and families
on the probabilities of survival. This information allows for
patients and families to make informed choices regarding
their care and facilitates appropriate ICU utilization.490
Implementing Novel Predictive Parameters in Apheresis
Bethany King 1, Joshua Geary 2, Donna Crown 3,
Olive Sturtevant 1, Sharon Anderson 2, Karl Stasko 2,
Amy Emmert 4, C John Luckey 3. 1 Cell Therapy Quality
Assurance, Dana Farber Cancer Institute, Boston, MA; 2 Cell
Manipulation Core Facility, Dana Farber Cancer Institute;
3 Kraft Family Blood Donor Center, Brigham and Women's
Hospital; 4 Dana-Farber Cancer Institute, Boston, MA
Background: Reducing the time a patient is present in the
apheresis facility for autologous collection can help trans-
plant centers better utilize staff. Waiting for CD34+ cell count
results can delay start of apheresis for an hour or more. An
alternative test for prediction of stem cell mobilization using
HPC count to provide a quickly resulted (<5 minutes) proxy
for CD34+ results was explored. The HPC parameter is
measured using the Sysmex XE analyzer and is a less mature
cell with a 0.7 correlation with CD34+ cell count. We
implemented this test in combination with CD34+ testing to
identify patients who could start apheresis without waiting
for the CD34+ results. The goal was to reduce patient wait
time and deliver the product to the processing lab earlier,
with better utilization of technicians.
Methods: Using previously collected data, our center
decided to collect immediately any autologous patient not
mobilized with AMD who had an HPC value of over 30. The
cutoff was set high to minimize false positives, patients who
were run who ultimately had low counts. Based on the
guideline we established, we allocated patients to two
subsets: move to apheresis without waiting for CD34+
results or hold for CD34+ results. Patients who were held
pending CD34+ results were subsequently assessed accord-
ing to Institute standards. We collected baseline and post-
implementation data to assess howmuch time patients were
spending in apheresis and the time that elapsed before
delivery to the processing lab pre- and post-implementation.
Results: Of the eligible patients, 62% could begin apheresis
upon HPC resulting and 38% were categorized as needing to
wait for CD34+ results. In the ﬁrst 3 months post-imple-
mentation, patients who initiated collection based on the
HPC parameter were found to begin collecting 40 minutes
earlier than historic averages, and over an hour earlier than
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However, it was observed that the lab receipt time for these
patients was equivalent to our baseline. Using the HPC
parameter and a cutoff of 30, mobilization was adequately
predicted 86.4% of the time. For Table 1 n¼66.Table 1
HPC > 30 HPC < 30
CD34+ > 10 56.1% 6.1%
CD34+ < 5 7.6% 30.3%Conclusion: Based on these ﬁndings, it was determined that
this approach for evaluating patient readiness for collection
provides an opportunity to reduce time from arrival in the
donor room to start of collection. However, further adjust-
ments in communication and scheduling the delivery of the
product to the processing laboratory is required to take
advantage of the earlier availability of the product. Upon
further investigation, the earlier arrival of products coincided
with times that had been historically underutilized and had
been repurposed for lab meetings and other tasks. This
approach does provide an opportunity to reduce downtime
in the overall process and better control utilization of
resources.
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Improving Patient Satisfaction in the Outpatient BMT
Clinic Setting
S. Elizabeth Sharf 1, Ann Hornback 2. 1 Clinical Director, BMT
Program, University of North Carolina, Chapel Hill, NC; 2 BMT
Outpatient Clinic, University of North Carolina Healthcare,
Chapel Hill, NC
Patient satisfaction is an overall goal for every clinical area,
and many hospitals utilize a standardized survey tool to
obtain data on how each speciﬁc inpatient or outpatient area
of the hospital is performing. The satisfaction of our patients
in the outpatient setting has been a primary focus of the UNC
Bone Marrow & Stem Cell Transplant Program. With larger
patient volumes, improving patient satisfaction scores
remains a priority.
During the ﬁrst quarter of 2011, our Press Ganey Patient
Satisfaction Scores e the measurement tool utilized by our
facility - was in the 78th percentile (for large health care
systems nationally). Realizing the frequency with which BMT
patients must spend time in the clinic setting, patient satis-
faction is crucial. At the close of Fiscal Year 2012, our BMT
Clinic ascended to the 95th percentile and was the top rated
clinic of all 84 outpatient clinics in our hospital system.
Creating an afternoon Clinic Huddle to review patients for
the following day was an integral part of improving patient
satisfaction. This huddle includes any teammember who has
a patient scheduled to be seen the next day. By meeting each
afternoon, communication within the team improved
substantially. Nurses had less confusion about labs reques-
ted, APPs were clear which orders needed to be written and
nurse coordinators reviewed any patient issues with the
group. Multidisciplinary updates provide an entire picture of
the patient. These huddles augmented team communication
to the point where add-on lab draws decreased substantially
over the ﬁrst year.
A separate phlebotomy area was established and patients
arrive at least thirty minutes prior to their appointment tohave labs drawn. This enables results to be in hand by the
time the provider sees the patient which expedites their
ability to create a plan of care while the patient remains in
the clinic.
Rounding occurred more frequently once patients were in
the exam room. Listening to the voice of the patient helped to
identify areas for improvement such as modifying pre-
transplant education or waiting room niceties.
Continuing to improve patient satisfaction is a vital
programmatic initiative as the number of patients we care
for in the outpatient setting continues to grow exponentially
as our transplant numbers increase annually. The ﬂexibility
of this Program's team to embrace new practices in order to
beneﬁt our patients' outpatient experience is a process
change worth sharing.492
Establishing a Post-Hematopoietic Stem Cell Transplant
Immunization Clinic: A Single Institution Experience
Jill Marie Vanak 1, Melanie Albano 2. 1 Ambulatory, Memorial
Sloan-Kettering Cancer Center, New York, NY; 2 Ambulatory
Bone Marrow Transplant, Memorial Sloan-Kettering Cancer
Center, New York, NY
Background: Antibody titers from vaccinations adminis-
tered prior to hematopoietic stem cell transplant (HSCT) for
vaccine-preventable diseases (e.g., tetanus, polio) decline 2-5
years after both allogeneic and autologous HSCT. The lack of
protective titers to vaccine preventable diseases poses
a threat to the immunosuppressed patient population. At
Memorial Sloan-Kettering Cancer Center, data indicate that
among those eligible to receive vaccination post HSCT, many
were not timely immunized or did not receive full recom-
mended series. An immunization clinic for this population
was established to increase access, provide timely vaccina-
tion administration, and decrease risk to vaccine preventable
disease for this population.
Population: Patients with leukemia, lymphoma or plasma
cell disorders at minimum of 9 months post allogeneic or
autologous HSCT, referred by a primary practitioner.
Project Description: To establish a centralized clinic led by
an advanced practice nurse dedicated to the immunization of
the HSCT population. The approach consisted of a multi-
phase implementation: implementation of standardized
treatment guidelines, creation of patient and staff education
materials, and the creation and implementation of
computer-based data collection systems.
Conclusion: Preliminary results of this project demonstrate
that the establishment of a centralized immunization clinic
increases access to care, improves patient education, and
promotes use of standardized guidelines at this institution.
This clinic served over 179 HSCT patients, cataloguing 363
unique visits, within its ﬁrst 12 months of inception. This
presentation will include data related to the feasibility of
establishing a vaccination clinic as an effective intervention
for purposes of increasing access and standardizing
evidence-based patient care. Data presented will include the
barriers to clinic implementation, rate of vaccination since
clinic inception, and the development of a documentation
system for data capture related to post HSCT immunization
practices. Increasing access and providing comprehensive
immunization treatment plans for this patient population
may reduce risk to vaccine preventable diseases.
